Curaleaf Holdings (CURLF) Gross Margin (2019 - 2026)
Curaleaf Holdings (CURLF) recorded quarterly Gross Margin of 48.51% in Q1 2026, little changed quarter-over-quarter from 48.58% in Q4 2025, and down 222.0% on a YoY basis from 39.76% in Q1 2025.
Curaleaf Holdings (CURLF) Gross Margin (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Gross Margin history runs 8 years deep, the most recent figure standing at 48.51% for Q1 2026.
- In Q1 2026, Gross Margin fell 222.0% year-over-year to 48.51%; the TTM figure through Mar 2026 stood at 49.19% (up 39.0% YoY), while the FY2025 annual figure was 49.76%, up 174.0% from the prior year.
- Gross Margin was 48.51% for Q1 2026 at Curaleaf Holdings, roughly flat from 48.58% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 57.42% in Q1 2022 to a low of 22.23% in Q4 2022.
- Historically, Gross Margin has averaged 47.43% across 5 years, with a median of 48.54% in 2024.
- The sharpest annual moves came in 2022 and 2023: Gross Margin slumped 2540 bps in 2022, then jumped 2301 bps in 2023.
- A 5-year view of Gross Margin shows it stood at 22.23% in 2022, then surged by 103 bps to 45.24% in 2023, then grew by 9 bps to 49.26% in 2024, then declined by 1 bps to 48.58% in 2025, then fell by 0 bps to 48.51% in 2026.
- The last three Gross Margin figures came in at 48.51% (Q1 2026), 48.58% (Q4 2025), and 49.88% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 49.52% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 71.66% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 82.93% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 49.50% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 98.31% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.26% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -293.83% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 61.20% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 65.25% |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | 48.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.51% |
| Dec 31, 2025 | 48.58% |
| Sep 30, 2025 | 49.88% |
| Jun 30, 2025 | 48.50% |
| Mar 31, 2025 | 50.74% |
| Dec 31, 2024 | 49.26% |
| Sep 30, 2024 | 48.56% |
| Jun 30, 2024 | 46.88% |
| Mar 31, 2024 | 47.47% |
| Dec 31, 2023 | 45.24% |
| Sep 30, 2023 | 45.04% |
| Jun 30, 2023 | 44.04% |
| Dec 31, 2022 | 22.23% |
| Sep 30, 2022 | 51.66% |
| Jun 30, 2022 | 54.95% |
| Mar 31, 2022 | 57.42% |
| Dec 31, 2021 | 47.63% |
| Sep 30, 2021 | 57.73% |
| Jun 30, 2021 | 59.11% |
| Mar 31, 2021 | 54.18% |